Neuroendocrine Cancer

Lutathera plus Sandostatin improved progression-free survival in patients with advanced gastric neuroendocrine tumors, research showed.

Patients with neuroendocrine tumors or neuroblastoma could be treated with a different approach based on a protein that may be a potential biomarker.

After cancer, taking baby steps towards stuff you want to do is what matters.

After being diagnosed with a neuroendocrine cancer, I underwent seven phases of resiliency.

We all know that stress is bad.

I have cancer and don't believe in god, can I still be spiritual?

Treatment combination of Lutathera and Sandostatin improved outcomes for patients with gastroenteropancreatic neuroendocrine tumors.

Patients "need to be proactive" as they coordinate care between two diseases.

From Jill Martin revealing an updated about her cancer to Casey DeSantis announcing breast cancer diagnosis, this is what’s happening in the oncology space this week.

From Stand Up to Cancer honoring survivors at a Minor League baseball game, to Maria Menounos showing her cancer scars on Instagram, here’s what’s happening in the oncology space this week.

I was diagnosed with cancer just as the pandemic hit.

Sure, knowledge is power, but there’s comfort in naïveté, too, when it comes to expectations for cancer care.

A cancer diagnosis often means putting your life in the hands of people you hardly know.

The day I got diagnosed with cancer, I went from “person” to “patient” — and the title has followed me ever since.

In part of the “Star Wars” saga, a character mentions that rebellions are built on hope. After being diagnosed with cancer, I’ve realized that the same is true for patients with the disease.

Experts are concerned that the train derailment in Ohio may pose cancer risks down the line.

A new standard of care for advanced pancreatic neuroendocrine tumors demonstrates improvements in survival and tumor shrinkage.

Researchers just launched a phase 2 trial evaluating iadademstat plus paclitaxel in patients with relapsed/refractory neuroendocrine cancer, including those with small cell lung cancer.

Maintaining independence was found to the be the most common health care goal in patients with stage 4 neuroendocrine tumors, a recent survey found.

A phase 2 clinical trial will evaluate iadademstat for patients with relapsed or refractory high-grade neuroendocrine carcinoma.

A novel drug, MRT-2359, will be studied in a phase 1/2 trial for patients with MYC-driven cancers.

The Food and Drug Administration will fast track the development and review of ITM-11 for the treatment of gastroenteropancreatic neuroendocrine tumors.

I’ve always received impeccable care at my cancer center, but a recent experience made me feel like I was no longer a priority.

Before being diagnosed with neuroendocrine cancer, I started to live a healthier life and took notice of some concerning symptoms.

The Food and Drug Administration plans on reviewing multiple new cancer therapies this spring.

When I was first diagnosed with a stage 4 neuroendocrine tumor in my small intestine, I went through three stages of coping with my cancer: anger, planning and living life.

The phase 3 COMPOSE trial will look at the efficacy of using 177lu-edotreotide — a novel radiopharmaceutical that is designed to limit radiation exposure to normal tissue — in patients with later stage neuroendocrine tumors.

For patients with neuroendocrine tumors that have spread, curating a liver-directed approach may make their treatment process less risky and less invasive, according to an expert.

Catching tumors through imaging at an early stage can help guide treatment decisions and may improve a patient’s quality of life — which is why it’s important for patients to stay educated on their options.

The combination of Inlyta (axitinib) and the synthetic hormone octreotide acetate failed to significantly improve progression-free survival, compared to placebo with the synthetic hormone. However, the results indicated the Inlyta-based combination did improve disease response in patients versus the placebo-based combination.